San Diego Business Journal

Cytori Aims for $10M Through Subscription Agreements Sale

By Meghana Keshavan Friday, May 30, 2014

San Diego regenerative medicine company Cytori Therapeutics Inc. has entered into subscription agreements with some of its institutional investors to raise about $10 million.

Cytori (Nasdaq: CYTX) will issue and sell about 4 million shares to the investors at $2.47 per unit. Its stock closed at $2.41 May 30.

The company, which is developing cell therapies for heart disease and other disorders, said it plans to use the proceeds for general corporate purposes.